| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 3 |
| NetGPI | no | yes: 0, no: 3 |
Related structures:
AlphaFold database: A0A3S5H6F8
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 3 |
| GO:0004386 | helicase activity | 2 | 3 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 3 |
| GO:0140657 | ATP-dependent activity | 1 | 3 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 223 | 227 | PF00656 | 0.650 |
| CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.619 |
| CLV_NRD_NRD_1 | 230 | 232 | PF00675 | 0.646 |
| CLV_NRD_NRD_1 | 264 | 266 | PF00675 | 0.635 |
| CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.620 |
| CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.619 |
| CLV_PCSK_KEX2_1 | 230 | 232 | PF00082 | 0.629 |
| CLV_PCSK_KEX2_1 | 264 | 266 | PF00082 | 0.635 |
| CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.620 |
| CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.602 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.652 |
| DOC_CDC14_PxL_1 | 190 | 198 | PF14671 | 0.619 |
| DOC_CKS1_1 | 210 | 215 | PF01111 | 0.644 |
| DOC_CKS1_1 | 69 | 74 | PF01111 | 0.613 |
| DOC_PP2B_LxvP_1 | 109 | 112 | PF13499 | 0.604 |
| DOC_PP2B_LxvP_1 | 200 | 203 | PF13499 | 0.619 |
| DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.638 |
| DOC_USP7_MATH_1 | 125 | 129 | PF00917 | 0.633 |
| DOC_USP7_MATH_1 | 189 | 193 | PF00917 | 0.589 |
| DOC_USP7_MATH_1 | 220 | 224 | PF00917 | 0.660 |
| DOC_USP7_MATH_1 | 263 | 267 | PF00917 | 0.630 |
| DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.551 |
| DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.600 |
| DOC_WW_Pin1_4 | 129 | 134 | PF00397 | 0.545 |
| DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.598 |
| DOC_WW_Pin1_4 | 209 | 214 | PF00397 | 0.640 |
| DOC_WW_Pin1_4 | 68 | 73 | PF00397 | 0.625 |
| LIG_14-3-3_CanoR_1 | 248 | 254 | PF00244 | 0.599 |
| LIG_14-3-3_CanoR_1 | 264 | 269 | PF00244 | 0.519 |
| LIG_Actin_WH2_2 | 254 | 271 | PF00022 | 0.619 |
| LIG_FHA_1 | 105 | 111 | PF00498 | 0.590 |
| LIG_FHA_1 | 235 | 241 | PF00498 | 0.622 |
| LIG_Integrin_RGD_1 | 224 | 226 | PF01839 | 0.652 |
| LIG_LIR_Gen_1 | 59 | 69 | PF02991 | 0.556 |
| LIG_LIR_LC3C_4 | 107 | 111 | PF02991 | 0.614 |
| LIG_LIR_Nem_3 | 59 | 64 | PF02991 | 0.554 |
| LIG_PAM2_1 | 52 | 64 | PF00658 | 0.551 |
| LIG_PDZ_Class_2 | 291 | 296 | PF00595 | 0.577 |
| LIG_SH3_1 | 63 | 69 | PF00018 | 0.559 |
| LIG_SH3_1 | 74 | 80 | PF00018 | 0.548 |
| LIG_SH3_2 | 69 | 74 | PF14604 | 0.583 |
| LIG_SH3_3 | 107 | 113 | PF00018 | 0.608 |
| LIG_SH3_3 | 183 | 189 | PF00018 | 0.644 |
| LIG_SH3_3 | 199 | 205 | PF00018 | 0.469 |
| LIG_SH3_3 | 286 | 292 | PF00018 | 0.579 |
| LIG_SH3_3 | 63 | 69 | PF00018 | 0.592 |
| LIG_SH3_3 | 74 | 80 | PF00018 | 0.553 |
| MOD_CDK_SPxK_1 | 115 | 121 | PF00069 | 0.602 |
| MOD_CDK_SPxK_1 | 68 | 74 | PF00069 | 0.581 |
| MOD_CDK_SPxxK_3 | 115 | 122 | PF00069 | 0.604 |
| MOD_CK1_1 | 104 | 110 | PF00069 | 0.623 |
| MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.700 |
| MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.613 |
| MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.779 |
| MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.672 |
| MOD_GlcNHglycan | 274 | 277 | PF01048 | 0.523 |
| MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.568 |
| MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.620 |
| MOD_GSK3_1 | 100 | 107 | PF00069 | 0.579 |
| MOD_GSK3_1 | 125 | 132 | PF00069 | 0.639 |
| MOD_GSK3_1 | 216 | 223 | PF00069 | 0.656 |
| MOD_GSK3_1 | 234 | 241 | PF00069 | 0.624 |
| MOD_GSK3_1 | 249 | 256 | PF00069 | 0.487 |
| MOD_GSK3_1 | 259 | 266 | PF00069 | 0.542 |
| MOD_GSK3_1 | 52 | 59 | PF00069 | 0.540 |
| MOD_GSK3_1 | 92 | 99 | PF00069 | 0.649 |
| MOD_LATS_1 | 96 | 102 | PF00433 | 0.646 |
| MOD_N-GLC_1 | 278 | 283 | PF02516 | 0.602 |
| MOD_NEK2_1 | 114 | 119 | PF00069 | 0.601 |
| MOD_NEK2_1 | 196 | 201 | PF00069 | 0.618 |
| MOD_NEK2_1 | 216 | 221 | PF00069 | 0.512 |
| MOD_NEK2_1 | 253 | 258 | PF00069 | 0.602 |
| MOD_NEK2_1 | 56 | 61 | PF00069 | 0.548 |
| MOD_PKA_1 | 264 | 270 | PF00069 | 0.638 |
| MOD_PKA_2 | 263 | 269 | PF00069 | 0.635 |
| MOD_Plk_4 | 105 | 111 | PF00069 | 0.618 |
| MOD_Plk_4 | 56 | 62 | PF00069 | 0.550 |
| MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.602 |
| MOD_ProDKin_1 | 129 | 135 | PF00069 | 0.546 |
| MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.595 |
| MOD_ProDKin_1 | 209 | 215 | PF00069 | 0.643 |
| MOD_ProDKin_1 | 68 | 74 | PF00069 | 0.631 |
| TRG_DiLeu_BaLyEn_6 | 110 | 115 | PF01217 | 0.602 |
| TRG_DiLeu_BaLyEn_6 | 60 | 65 | PF01217 | 0.557 |
| TRG_ER_diArg_1 | 208 | 211 | PF00400 | 0.640 |
| TRG_ER_diArg_1 | 29 | 31 | PF00400 | 0.610 |
| TRG_ER_diArg_1 | 78 | 81 | PF00400 | 0.613 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3Q8I7P2 | Leishmania donovani | 100% | 100% |
| E9AG98 | Leishmania infantum | 81% | 97% |